Kanabo Research Share Price
Kanabo is developing and engineering a proprietary second generation version of their vapepod device.
Kanabo research share price. Kanabo research share price and news. Kanabo has done extensive research and development in order to create high quality cannabis extract formulas and has paired them with innovative extract vaporizers currently undergoing certification processes for medical validation. Pre approvals for r d licences issued by israeli moh. Kanabo focuses on vaporization for medical application developing targeted cannabis formulations designed to work in synergy with their medically certified delivery systems.
Kanabo focuses on building. Submitted two provisional patents. Otc formulations focus serenity revive developed. Spinnaker opportunities plc london based cash shell confirms purchase of kanabo research ltd.
Kanabo tetsubo samurai generic type template pattern blueprint diy pdf digital donwload vector printable cosplay costume larp pdf fingerprintprops. From shop fingerprintprops. Sale price 11 74 11 74 13 04 original price 13 04 10 off. Israel s kanabo research launches pioneering medical cannabis extraction and vaporization solutions.
Kanabo was born out of founder and ceo avihu tamir s personal experience working with medical cannabis patients in israel a pioneering leader in the field of medical cannabis. Kanabo research is an r amp d company based in israel that innovates cutting edge solutions for the medical cannabis industry. Finance march 10 2016. Vapepod md will function as both a delivery device and a data collection device through an affiliated mobile application.
Clinical and validation activities including the most rigorous safety and efficiency tests available today have. Kanabo research aims vaporization at medicinal cannabis users. The times of israel march 16 2017. Kanabo reserach has its sights on becoming the first medical cannabis company to list on the main market of the london stock exchange.
Israel gives rise to the ganjapreneur drawing new opportunities for green investment. Israel is the first country to allow medical and scientific research of cannabis and the first country to establish a national medical cannabis program for patients. Start of work in r d lab in the weizmann science park israel. Kanabo research is an r d company that innovates cutting edge solutions for the medical cannabis industry.